Our vision is a world of mental wellbeing.
COMPASS is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first programme is researching how COMP360 psilocybin therapy could help people with treatment-resistant depression.
We want to transform the patient experience in mental health care.
Everyone has a mental health story, be it their own, or that of a friend or loved one. Our people bring their stories, and a wide range of backgrounds and skills to COMPASS.
Our research is evidence-based and underpinned by a commitment to find better ways to support and empower people suffering with poor mental health.
News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology, and digital platforms.
COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression
COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK